Gradient Investments’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-194,446
Closed -$19.2M 388
2025
Q3
$19.2M Buy
194,446
+8,713
+5% +$863K 0.32% 97
2025
Q2
$16.9M Sell
185,733
-2,170
-1% -$210K 0.31% 102
2025
Q1
$21.3M Buy
187,903
+18,931
+11% +$2.03M 0.43% 79
2024
Q4
$17.8M Buy
168,972
+8,787
+5% +$943K 0.36% 79
2024
Q3
$17.3M Buy
160,185
+29,835
+23% +$3.26M 0.36% 76
2024
Q2
$14.1M Buy
130,350
+19,224
+17% +$2.27M 0.32% 110
2024
Q1
$14.7M Buy
111,126
+110,941
+59,968% +$13.9M 0.34% 111
2023
Q4
$22.5K Hold
185
﹤0.01% 686
2023
Q3
$20.8K Hold
185
﹤0.01% 675
2023
Q2
$26.9K Hold
185
﹤0.01% 632
2023
Q1
$23.9K Hold
185
﹤0.01% 645
2022
Q4
$23.6K Hold
185
﹤0.01% 664
2022
Q3
$19K Hold
185
﹤0.01% 682
2022
Q2
$19K Hold
185
﹤0.01% 662
2022
Q1
$24K Sell
185
-6
-3% -$723 ﹤0.01% 616
2021
Q4
$24K Hold
191
﹤0.01% 624
2021
Q3
$27K Hold
191
﹤0.01% 596
2021
Q2
$30K Hold
191
﹤0.01% 567
2021
Q1
$30K Buy
+191
New +$29.6K ﹤0.01% 556
2020
Q2
Sell
-7
Closed -$1K 1222
2020
Q1
$1K Buy
+7
New +$918 ﹤0.01% 1055
2019
Q4
Sell
-21
Closed -$3K 1255
2019
Q3
$3K Buy
21
+10
+91% +$1.29K ﹤0.01% 899
2019
Q2
$1K Buy
+11
New +$1.29K ﹤0.01% 991
2019
Q1
Sell
-19
Closed -$2K 1022
2018
Q4
$2K Buy
+19
New +$2.14K ﹤0.01% 834
2018
Q1
Sell
-3
Closed 1187
2017
Q4
$0 Buy
+3
New +$339 ﹤0.01% 1100

Other funds holding ZBH

Gradient Investments's ZBH Position: Q4 2025 in Review

Gradient Investments sold out of Zimmer Biomet (ZBH) in Q4 2025, closing a stake of 194,446 shares — an estimated $19.2M sold.

Gradient Investments first reported a position in ZBH in Q4 2017 and held it in 24 quarters. The position peaked at $21.3M in Q1 2025. 945 funds tracked by Wall St. Rank hold ZBH as of Q4 2025.

  • Gradient Investments reported no remaining Zimmer Biomet position as of Q4 2025 after selling out during the quarter.
  • Gradient Investments sold 194,446 Zimmer Biomet shares in Q4 2025, an estimated $19.2M.
  • Gradient Investments first reported a position in Zimmer Biomet in Q4 2017 and held it in 24 quarters.
  • Gradient Investments's Zimmer Biomet position peaked at $21.3M in Q1 2025.
  • 945 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2025.

Based on Gradient Investments's 13F filing for Q4 2025, filed 8 Jan 2026.